Drug Trial Radar · NCT05868122
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
143
Actual
Start
Sep 7, 2023
Primary completion
May 25, 2024
Study completion May 30, 2024
Sponsor
- Lead sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)Johnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- May 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate effectiveness of a fixed combination of acetaminophen/naproxen sodium compared with placebo for reduction of pain when administered as multiple doses over a 48-hour period.
Conditions
- Pain
Interventions
Acetaminophen/Naproxen Sodium Fixed CombinationDrug
Fixed combination of Acetaminophen/Naproxen Sodium will be administered orally.
PlaceboDrug
Placebo will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time-weighted Sum of Pain Intensity Difference Score From 0 to 24 Hours After Dosing (SPID 0-24)Time frame: Baseline (0 hour) up to 24 hours post-dose
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Lotus Clinical Research, LLC
New Providence, New Jersey
First Surgical Hospital
Bellaire, Texas
The Heights Hospital / Memorial Herman Village
Houston, Texas
Endeavor Clinical Trails
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.